These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Reddening of the upper central incisors associated with periapical granuloma in lepromatous leprosy. Rendall JR; McDougall AC Br J Oral Surg; 1976 Mar; 13(3):271-7. PubMed ID: 1063039 [TBL] [Abstract][Full Text] [Related]
24. Lymphocyte transformation test in healthy contacts of patients with leprosy. I. Influence of exposure to leprosy within a household. Menzel S; Bjune G; Kronvall G Int J Lepr Other Mycobact Dis; 1979 Jun; 47(2):138-52. PubMed ID: 378871 [TBL] [Abstract][Full Text] [Related]
25. Prevalence of colour blindness among patients with leprosy. Shwe T Indian J Lepr; 1992; 64(4):483-6. PubMed ID: 1308523 [TBL] [Abstract][Full Text] [Related]
26. Lepromatous leprosy: a review and case report. Chimenos Küstner E; Pascual Cruz M; Pinol Dansis C; Vinals Iglesias H; Rodríguez de Rivera Campillo ME; López López J Med Oral Patol Oral Cir Bucal; 2006 Nov; 11(6):E474-9. PubMed ID: 17072249 [TBL] [Abstract][Full Text] [Related]
27. Influence of Mycobacterium leprae and its soluble products on the cutaneous responsiveness of leprosy patients to antigen and recombinant interleukin 2. Kaplan G; Sampaio EP; Walsh GP; Burkhardt RA; Fajardo TT; Guido LS; de Miranda Machado A; Cellona RV; Abalos RM; Sarno EN Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6269-73. PubMed ID: 2668961 [TBL] [Abstract][Full Text] [Related]
28. Survey of eye complications in leprosy in Prakasam District (Andhra Pradesh). Reddy SC; Raju BD; Achary NR Lepr India; 1981 Apr; 53(2):231-7. PubMed ID: 7253576 [TBL] [Abstract][Full Text] [Related]
29. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants. Reitan LJ; Closs O; Belehu A Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003 [TBL] [Abstract][Full Text] [Related]
30. Analysis of T-cell and B-cell responses to recombinant M. leprae antigens in leprosy patients and in healthy contacts: significant T-cell responses to antigens in M. leprae nonresponders. Thole JE; Janson AA; Kifle A; Howe RC; McLean K; Nurilygn A; Filley E; Shannon EJ; Bulla GJ; Hermans J Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):369-80. PubMed ID: 7594920 [TBL] [Abstract][Full Text] [Related]
31. Post-kala-azar dermal leishmaniasis and leprosy: case report and literature review. Trindade MA; Silva LL; Braz LM; Amato VS; Naafs B; Sotto MN BMC Infect Dis; 2015 Nov; 15():543. PubMed ID: 26592919 [TBL] [Abstract][Full Text] [Related]
32. HLA-DQ molecules and the control of Mycobacterium leprae-specific T cell nonresponsiveness in lepromatous leprosy patients. Ottenhoff TH; Walford C; Nishimura Y; Reddy NB; Sasazuki T Eur J Immunol; 1990 Oct; 20(10):2347-50. PubMed ID: 1700754 [TBL] [Abstract][Full Text] [Related]
36. Cutaneous rhinosporidiosis in a patient of lepromatous leprosy--a case report. Porichha D; Pradhan SC; Agrawal MN Indian J Lepr; 1986; 58(4):626-7. PubMed ID: 3572106 [TBL] [Abstract][Full Text] [Related]
37. Defective production of monocyte-activating cytokines in lepromatous leprosy. Horwitz MA; Levis WR; Cohn ZA J Exp Med; 1984 Mar; 159(3):666-78. PubMed ID: 6366107 [TBL] [Abstract][Full Text] [Related]
38. Cutaneous leishmaniasis cases seen in two years at the All Africa Leprosy and Rehabilitation Training Centre Hospital. Sarojini PA; Humber DP; Yemane-Berhan T; Fekete E; Belehu A; Mock B; Warndorff JA Ethiop Med J; 1984 Jan; 22(1):7-11. PubMed ID: 6690307 [No Abstract] [Full Text] [Related]
39. Importance of nasal lesions in early lepromatous leprosy. Barton RP Ann R Coll Surg Engl; 1975 Dec; 57(6):309-12. PubMed ID: 1108744 [TBL] [Abstract][Full Text] [Related]